In order to view this content, your browser requires a more recent version of the Adobe Flash Player.
Step 1) Bookmark this page.
Step 2) Click Get Flash and follow the install instructions on Adobe's web site.
Step 3) Once the installation is complete, re-launch your browser and select the bookmark for this page.

        

Think Rebate. Click Here.

If you're looking for a solution in the fight against acne, you're in the right place. Prescription strength TAZORAC® Cream and Gel 0.1% is clinically shown to have effective acne-fighting power, 1-4 so it can knock out even stubborn acne. What more can you ask for? Say hello to TAZORAC®.

 
 

TAZORAC® (tazarotene) Cream 0.1% is indicated for acne vulgaris.
TAZORAC® (tazarotene) Gel 0.1% is indicated for mild to moderate facial acne vulgaris.

Important Safety Information

Warnings

Retinoids may cause fetal harm when administered to a pregnant woman. Do not use TAZORAC® Cream and Gel if you are pregnant, attempting to become pregnant or at high risk of pregnancy. Consult your physician for adequate birth control measures if you are a female of child-bearing potential. To help assure that you are not pregnant when you begin use, take a pregnancy test within 2 weeks prior to beginning to use TAZORAC® Cream or Gel and/or begin taking TAZORAC® Cream or Gel during a normal menstrual period.

TAZORAC® Cream and Gel should not be used if you are allergic to any of its ingredients. Please see complete Information for Patients for a list of ingredients.

Precautions

TAZORAC® Cream and Gel should not be used if you are also taking other drugs that increase your sensitivity to sunlight (e.g., thiazides, tetracyclines, fluoroquinolones, phenothiazines, sulfonamides). Inform your physician if you are taking any other medications. Use protective clothing and sunscreens of at least SPF 15 during the day when using TAZORAC® Cream and Gel. Do not use TAZORAC® Cream and Gel if you have sunburn, eczema, or other continuing skin condition. Use TAZORAC® Cream and Gel with caution if you are using other topical products that might dry or irritate the skin.

The most common side effects of TAZORAC® Cream and Gel 0.1% are peeling, burning/stinging, dry skin, red skin, and itching.

Please click here for full prescribing information for TAZORAC® Cream and Gel 0.1%.

Allergan Dermatology
©2008 Allergan, Inc., Irvine, CA 92612. ® marks owned by Allergan, Inc.
  1. Shalita A, Miller B, Menter A, Abramovits W, Loven K, Kakita L. Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized parallel-group study. J Drugs Dermatol. 2005;4(2):153-158.
  2. Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. Cutis. 2002;69(suppl 2):4-11.
  3. Leyden JJ, Tanghetti EA, Miller B, Ling M, Berson D, Lee J. Once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.1% microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. Cutis. 2002;69(suppl 2):12-19.
  4. Webster GF, Berson D, Stein LF, Fivenson DP, Tanghetti EA, Ling M. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. Cutis. 2001;67(suppl 6):4-9.